Xilio Therapeutics, Inc.XLONASDAQ

Revenue (LTM)

$6M

Net Income (LTM)

$-58M

+23.8% YoY

Free Cash Flow

$-18M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	6
Gross Profit	-1	-1↓40.8%	0	0	6
Operating Income	-55	-75↓37.5%	-89↓18.8%	-79↑11.2%	-61↑23.4%
Net Income	-55	-76↓37.3%	-88↓16.4%	-76↑13.4%	-58↑23.8%
EBITDA	-54	-74↓37.6%	-87↓18.5%	-77↑11.5%	-58↑24.9%
EPS Diluted	-1475.88	-189.28↑87.2%	-45.08↑76.2%	-38.92↑13.7%	-15.26↑60.8%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	19	198↑929.5%	120↓39.2%	45↓62.9%	55↑23.7%
Total Current Assets	21	203↑883.6%	124↓38.5%	48↓61.3%	60↑25.2%
Total Assets	36	222↑510.2%	139↓37.2%	61↓56.2%	71↑16.7%
Total Current Liabilities	22	13↓42.3%	21↑65.3%	16↓24.4%	27↑70.8%
Total Liabilities	42	36↓13.1%	34↓7.3%	24↓28.1%	53↑121.9%
Total Equity	-5	185↑3608.6%	106↓43.0%	37↓65.1%	18↓52.2%
Total Debt	22	21↓5.3%	20↓3.8%	11↓42.5%	8↓28.9%
Net Debt	3	-177↓6796.3%	-100↑43.4%	-33↑66.9%	-47↓41.8%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-36	-81↓123.7%	-76↑6.2%	-69↑9.4%	-18↑73.2%
Capital Expenditure	-2	-1↑49.7%	-2↓69.7%	-0↑74.0%	-0↑92.6%
Free Cash Flow	-38	-82↓113.8%	-78↑5.2%	-69↑10.9%	-18↑73.4%
Stock-Based Comp	1	5↑282.6%	8↑69.9%	7↓12.4%	6↓12.8%
Net Change in Cash	-28	179↑733.0%	-78↓143.4%	-76↑2.6%	11↑114.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance